Last $0.11 USD
Change Today +0.0199 / 20.95%
Volume 200.3K
ERGO On Other Exchanges
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

entia biosciences inc (ERGO) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/12/14 - $0.75
52 Week Low
02/20/15 - $0.05
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ENTIA BIOSCIENCES INC (ERGO)

Related News

No related news articles were found.

entia biosciences inc (ERGO) Related Businessweek News

No Related Businessweek News Found

entia biosciences inc (ERGO) Details

Entia Biosciences, Inc., a biotechnology company, is engaged in the discovery, formulation, and marketing of functional ingredients used in medical foods, nutraceuticals, cosmetics, and other products. The company’s portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an essential antioxidant. It also offers natural organic nutraceutical mushroom dietary supplement products, including ImmuSANO, which nutritionally addresses the needs of the immune system by balancing cellular function and promoting a stronger immune system; GlucoSANO that is designed to assist in maintaining normal cellular metabolism and stabilizing blood sugar levels; and Groh that nutritionally supports hair follicles and nail beds. Entia Biosciences, Inc. provides its products directly to consumers online, through hair salons, and other resellers in North America. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon.

8 Employees
Last Reported Date: 03/31/14
Founded in 2007

entia biosciences inc (ERGO) Top Compensated Officers

Chairman, Chief Executive Officer, President,...
Total Annual Compensation: $300.0K
Chief Operating Officer and Vice President of...
Total Annual Compensation: $175.0K
Compensation as of Fiscal Year 2013.

entia biosciences inc (ERGO) Key Developments

Entia Biosciences, Inc announced delayed 10-Q filing

On 08/15/2014, Entia Biosciences, Inc announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Entia Biosciences, Inc. Announces Partnership Agreement with Tan Republic Franchise Company

Entia Biosciences Inc. announced a partnership agreement with Tan Republic Franchise Company. This strategic partnership follows the release of independent studies on the cellular protection benefits of the potent antioxidant Ergothioneine. Entia Biosciences will continue to explore this secondary market and continue to expand its products with the all-natural source of Ergothioneine with the benefits of targeted nutrition and cellular protection. Ergothioneine may stimulate certain enzymes involved in antioxidant response and repair mechanisms and also have a role in cell proliferation. In addition, Ergothioneine protects against a variety of other ROS and reactive nitrogen species providing cytoprotection at multiple levels.

Entia Biosciences, Inc Auditor Raises 'Going Concern' Doubt

Entia Biosciences, Inc filed its 10-K on Mar 31, 2014 for the period ending Dec 31, 2013. In this report its auditor, Peterson Sullivan PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ERGO:US $0.11 USD +0.0199

ERGO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Glanbia PLC €16.30 EUR +0.15
Herbalife Ltd $31.01 USD -3.81
View Industry Companies

Industry Analysis


Industry Average

Valuation ERGO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.4x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENTIA BIOSCIENCES INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at